Novavax, Inc. (NVAX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Novavax, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Novavax, Inc. had a return of 2.71% year-to-date (YTD) and -34.87% in the last 12 months. Over the past 10 years, Novavax, Inc. had an annualized return of -24.56%, while the S&P 500 had an annualized return of 10.64%, indicating that Novavax, Inc. did not perform as well as the benchmark.

The current rank of NVAX is 31, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The charts below present risk-adjusted performance metrics for Novavax, Inc. (NVAX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.

The Drawdowns chart displays portfolio losses from any high point along the way.

The table below displays the maximum drawdowns of the Novavax, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Novavax, Inc. was 98.82%, occurring on Feb 5, 2024. The portfolio has not yet recovered.

The current Novavax, Inc. drawdown is 98.46%.

The current Novavax, Inc. volatility is 14.48%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.